CC
RXST icon

Centiva Capital’s RxSight RXST Stock Holding History

Centiva Capital’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$133K Sell
27,690
-6,596
-19% -$39.8K ﹤0.01% 1491
2026
Q1 		$211K Buy
34,286
+18,725
+120% +$155K ﹤0.01% 1252
2025
Q4 		$162K Buy
+15,561
New +$156K ﹤0.01% 1017
2025
Q2 		– Sell
-28,815
Closed -$728K – 1978
2025
Q1 		$728K Buy
+28,815
New +$856K 0.02% 625
2024
Q2 		– Sell
-8,726
Closed -$450K – 2455
2024
Q1 		$450K Buy
+8,726
New +$428K 0.01% 1039

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Centiva Capital's RXST Position: Q2 2026 in Review

Centiva Capital reduced its RxSight (RXST) stake by 19% in Q2 2026, selling an estimated $39.8K and leaving 27,690 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #1491.

Centiva Capital first reported a position in RXST in Q1 2024 and has held it in 5 quarters since. The position peaked at $728K in Q1 2025. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Centiva Capital held 27,690 shares of RxSight worth $133K as of Q2 2026.
  • Centiva Capital sold 6,596 RxSight shares in Q2 2026, an estimated $39.8K.
  • RxSight made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1491 holding.
  • Centiva Capital first reported a position in RxSight in Q1 2024 and has held it in 5 quarters since.
  • Centiva Capital's RxSight position peaked at $728K in Q1 2025.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.